Zirconium Zr 89-desferrioxamine B monoclonal antibody huJ591
Term · Oncology and biomedicine · MLC-T-ONC-017683
A radioimmunoconjugate comprised of the recombinant humanized monoclonal antibody J591 against prostate-specific membrane antigen (PSMA) conjugated to chelator desferrioxamine B (DFO-B) and labeled with the radioisotope zirconium Zr 89 with potential imaging property used in positron emission tomography (PET) imaging. Upon administration of zirconium Zr 89-desferrioxamine B monoclonal antibody huJ591, the antibody moiety binds to the extracellular domain of PSMA, and the radioisotope moiety may be detected using PET, thereby allowing the imaging and quantification of PSMA-expressing tumor cells. PSMA, or folate hydrolase is a cell surface peptidase highly expressed by malignant prostate epithelial cells and vascular endothelial cells of numerous solid tumor malignancies. In addition, upon PET imaging this agent provides high tumor:background tissue ratios.
| Identifier | MLC-T-ONC-017683 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | 89Zr-DFO-J591 |
| Synonyms | zirconium Zr 89 desferrioxamine B monoclonal antibody huJ591; 89Zr-DFO-huJ591 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017683",
"term": "Zirconium Zr 89-desferrioxamine B monoclonal antibody huJ591",
"field": "Oncology and biomedicine",
"definition": "A radioimmunoconjugate comprised of the recombinant humanized monoclonal antibody J591 against prostate-specific membrane antigen (PSMA) conjugated to chelator desferrioxamine B (DFO-B) and labeled with the radioisotope zirconium Zr 89 with potential imaging property used in positron emission tomography (PET) imaging. Upon administration of zirconium Zr 89-desferrioxamine B monoclonal antibody huJ591, the antibody moiety binds to the extracellular domain of PSMA, and the radioisotope moiety may be detected using PET, thereby allowing the imaging and quantification of PSMA-expressing tumor cells. PSMA, or folate hydrolase is a cell surface peptidase highly expressed by malignant prostate epithelial cells and vascular endothelial cells of numerous solid tumor malignancies. In addition, upon PET imaging this agent provides high tumor:background tissue ratios.",
"abbreviation": "89Zr-DFO-J591",
"synonyms": [
"zirconium Zr 89 desferrioxamine B monoclonal antibody huJ591",
"89Zr-DFO-huJ591"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/zirconium-zr-89-desferrioxamine-b-monoclonal-antibody-huj591/"
}
Record 17,655 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.